Key biomarkers for classical ALPS, such as the level of double-negative T (DNT) cells (TCRαβ+ CD4- CD8-), were not assessed at the time of initial diagnosis and prior to any treatment. The gene discussed is CD8A; the disease is autoimmune lymphoproliferative syndrome.